41,497 Shares in Waystar Holding Corp. $WAY Purchased by Ieq Capital LLC

Ieq Capital LLC acquired a new position in shares of Waystar Holding Corp. (NASDAQ:WAY) during the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund acquired 41,497 shares of the company’s stock, valued at approximately $852,000.

Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Clarkston Capital Partners LLC bought a new stake in Waystar in the first quarter worth $22,917,000. Hsbc Holdings PLC bought a new position in Waystar during the first quarter valued at $5,625,000. Perigon Wealth Management LLC bought a new position in Waystar during the second quarter valued at $878,000. Aurora Investment Counsel purchased a new stake in shares of Waystar in the second quarter valued at $1,765,000. Finally, Diamond Hill Capital Management LLC Investment Advisor purchased a new stake in shares of Waystar in the second quarter valued at $43,314,000.

Waystar News Roundup

Here are the key news stories impacting Waystar this week:

• Positive Sentiment: Waystar unveiled new AltitudeAI agentic capabilities designed to autonomously manage claims, denials, documentation and patient-billing workflows. The tools are intended to improve healthcare providers’ revenue-cycle efficiency and strengthen Waystar’s long-term growth opportunity. Waystar Launches New Agentic Solutions Transforming AI Into Action Across the Revenue Cycle
• Positive Sentiment: Royal Bank of Canada reaffirmed its Outperform rating and set a $44 price target, implying substantial potential upside from the referenced share price. Needham also maintained a Buy rating with a $33 target, reinforcing positive sell-side sentiment. Analyst Rating Updates
• Positive Sentiment: Management reaffirmed its long-term financial guidance during investor day, signaling that the company continues to expect its growth strategy—including AI-driven revenue-cycle automation—to remain on track. Waystar Analyst/Investor Day Slideshow
• Neutral Sentiment: Coverage of the product launch highlighted Waystar’s expansion of agentic AI across claims, denials and documentation. The rollout supports the company’s strategic positioning, but the financial impact and adoption pace have yet to be quantified. Waystar Expands AI-Powered Agentic Revenue Cycle Tools
• Negative Sentiment: RBC said the investor-day update lacked new KPIs, which disappointed investors seeking clearer evidence of execution, customer adoption and the measurable impact of the AI strategy. Waystar Reaffirms Long-Term Guidance, Lack of KPIs Disappoints, RBC Says

Waystar Stock Up 4.5%

Shares of NASDAQ WAY opened at $25.25 on Friday. The company has a debt-to-equity ratio of 0.36, a quick ratio of 1.85 and a current ratio of 1.85. The firm has a market capitalization of $4.84 billion, a price-to-earnings ratio of 36.07, a PEG ratio of 0.94 and a beta of 0.06. The stock has a 50 day moving average price of $22.71 and a 200 day moving average price of $22.66. Waystar Holding Corp. has a 52-week low of $17.26 and a 52-week high of $41.47.

Waystar (NASDAQ:WAY) last released its quarterly earnings data on Wednesday, July 29th. The company reported $0.43 earnings per share for the quarter, beating the consensus estimate of $0.40 by $0.03. Waystar had a return on equity of 7.03% and a net margin of 11.18%.The firm had revenue of $319.67 million during the quarter, compared to the consensus estimate of $316.21 million. During the same period in the previous year, the company posted $0.36 earnings per share. The firm’s quarterly revenue was up 18.1% on a year-over-year basis. Sell-side analysts expect that Waystar Holding Corp. will post 1.47 earnings per share for the current year.

Insider Transactions at Waystar

In other Waystar news, CEO Matthew J. Hawkins sold 60,038 shares of Waystar stock in a transaction dated Thursday, August 13th. The stock was sold at an average price of $25.01, for a total value of $1,501,550.38. Following the transaction, the chief executive officer owned 1,835,081 shares in the company, valued at $45,895,375.81. The trade was a 3.17% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 3.50% of the stock is owned by company insiders.

Wall Street Analysts Forecast Growth

A number of equities analysts recently commented on WAY shares. KeyCorp reaffirmed an “overweight” rating on shares of Waystar in a research note on Friday, July 31st. Royal Bank Of Canada reissued an “outperform” rating and issued a $44.00 price objective on shares of Waystar in a research note on Thursday. BMO Capital Markets restated an “outperform” rating on shares of Waystar in a research report on Thursday. Wall Street Zen cut Waystar from a “buy” rating to a “hold” rating in a research note on Sunday, May 24th. Finally, JPMorgan Chase & Co. reduced their price target on Waystar from $40.00 to $38.00 and set an “overweight” rating on the stock in a report on Thursday, April 30th. Three investment analysts have rated the stock with a Strong Buy rating, twenty have issued a Buy rating, two have issued a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $35.39.

About Waystar

Waystar (NASDAQ:WAY) is a leading provider of cloud-based revenue cycle management and payment solutions for healthcare organizations. The company’s unified platform streamlines the entire financial continuum of patient care, from eligibility verification and claim submission to payment reconciliation and patient billing. By automating key processes and improving claim accuracy, Waystar helps providers reduce administrative overhead, accelerate cash flow and enhance overall revenue performance.

At the core of Waystar’s offering is a SaaS-based architecture that integrates seamlessly with existing electronic health record (EHR) systems and payer networks.